MENOPUR® in a Gonadotropin-Releasing Hormone (GnRH) Antagonist Cycle With Single-Blastocyst Transfer in a High Responder Subject Population

PHASE4CompletedINTERVENTIONAL
Enrollment

620

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

January 26, 2017

Study Completion Date

February 2, 2017

Conditions
Infertility
Interventions
DRUG

menotropin

DRUG

recombinant FSH

Trial Locations (35)

Unknown

Bloom Reproductive Institute, Scottsdale

Fertility Treatment Center, Tempe

HRC Fertility, Encino

California Fertility Partners, Los Angeles

Colorado Center for Reproductive Medicine (CCRM), Lone Tree

Reproductive Associates of Delaware, Newark

Women's Medical Research Group, Clearwater

Fertility and IVF Center of Miami, Miami

Center for Reproductive Medicine, Orlando

The Reproductive Medicine Group, Tampa

Georgia Reproductive Specialists, Sandy Springs

Fertility Institute of Hawaii, Honolulu

Idaho Center for Reproductive Medicine, Boise

Fertility Centers of Illinois, Chicago

InVia Fertility Specialists, SC, Hoffman Estates

The Advanced IVF Institute, Naperville

Shady Grove Fertility Centers, Rockville

Shady Grove Fertility, Towson

IVF New England, Lexington

Boston IVF, Waltham

Fertility Center of Las Vegas, Las Vegas

Reproductive Medicine Associates of New Jersey, Basking Ridge

Reach, Charlotte

Carolina Conceptions, Raleigh

Abington Hospital, Jefferson Health, Abington

Main Line Fertility Center, Bryn Mawr

Coastal Fertility Specialists, Mt. Pleasant

Center for Assisted Reproduction, Bedford

Houston Fertility Institute, Houston

Center of Reproductive Medicine, Webster

Utah Fertility Center, Pleasant Grove

Reproductive Care Center, Sandy City

The Jones Institute for Reproductive Medicine, Norfolk

Virginia Center for Reproductive Medicine, Reston

Seattle Reproductive Medicine, Seattle

Sponsors
All Listed Sponsors
lead

Ferring Pharmaceuticals

INDUSTRY